Status: Recruiting
Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction studies (TTNCS). By assessing changes in nerve excitability parameters, the study seeks to enhance understanding of the pathophysiology of cis-PN and identify early markers of neurotoxicity in participants undergoing cisplatin-based chemotherapy.
Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ka-Wai HoUpdated: Apr 22, 2026Locations: 2
Eligibility criteria
Adults age ≥ 18 who will begin cisplatin-based chemotherapy either alone or in c... [+1]
Pre-existing peripheral neuropathy; [+18]